TGFB1 and neoplasm: We therefore aim to highlight the individual efficacy of Pirfenidone in inhibiting TGFβ pathway activation with subsequent recruitment of effector immune cells that result in diminished tumor growth and tumor size in vivo, which still leaves open mechanistic questions on the exact molecular mode of action.